Hunan Fangsheng Pharmaceutical Co.Ltd(603998) : it is proposed to raise no more than 270 million yuan to supplement working capital and repay bank loans

Hunan Fangsheng Pharmaceutical Co.Ltd(603998) 3 announced on March 6 that the total amount of funds raised by the proposed non-public offering shall not exceed 270 million yuan, and the issuing object is the new yuan industrial investment controlled by Zhang Qinghua, the actual controller of the company. After deducting the issuance expenses, all the raised funds will be used to supplement working capital and repay bank loans.